To procure deoxyribonucleic acid sequencers reagents kits for walter reed.
Ended Purchase Order Awarded Last action
- Contract number
- HT001425P0125
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $24,292
Award facts
- Contract value 100% obligated
- $24,291.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $1,421 | |
| Original award | $22,871 |
About this award
The Defense Health Agency awarded a firm fixed-price purchase order to Illumina, Inc. on June 20, 2025, valued at $24,291.59, for deoxyribonucleic acid (DNA) sequencing reagent kits and Illumina DNA testing equipment designated for Walter Reed Medical Center in Bethesda, Maryland. The contract carries no set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing technologies. The purchase order is scheduled for completion by August 1, 2025, and represents a direct procurement of critical laboratory consumables and equipment to support the medical center's diagnostic and research capabilities.
This award reflects the Defense Health Agency's ongoing relationship with Illumina, a leading biotechnology company specializing in genetic sequencing and genomic analysis platforms. As a for-profit manufacturer headquartered in San Diego, California, Illumina has established itself as a primary vendor for federal agencies requiring advanced sequencing instruments, reagents, and bioinformatics solutions across both civilian and defense sectors. The reagent kits and testing equipment procured under this order support Walter Reed's diagnostic and research operations, enabling sophisticated genetic analysis capabilities essential to military medical care and defense-related health initiatives.
Quick answers
Who was awarded contract HT001425P0125?
HT001425P0125 was awarded to Illumina, Inc. by Defense Health Agency (Department of Defense) on June 20, 2025.
How much is contract HT001425P0125 worth?
The government has obligated $24,292 on HT001425P0125.
Was contract HT001425P0125 competed?
The extent of competition for HT001425P0125 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award